MSD pays up to nearly $600m for Evaxion’s mystery vaccine candidate
Evaxion’s preclinical asset targets an unknown infectious disease in which there are no other vaccines available.
FDA delays approval decision for Sanofi’s MS treatment tolebrutinib
Biogen’s high-dose Spinraza turned down by FDA due to CMC troubles
Basilea in line for $159m of US federal funding for UTI antibiotic pill
Roche bids to broaden MS pipeline and strengthen Ocrevus influence
Sanofi announces $625m to venture capital arm
Analysis
View More
Themes
View MoreWhat does the EU Data Act mean for businesses?
The EU Data Act will shift data control away from manufacturers and large cloud providers to users of connected products and services and smaller EU companies.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Trump blames Covid-19 drugmakers for fuelling CDC turmoil
Oxford University and Ellison Institute link for AI vaccine research
FDA approves mRNA vaccines for new Covid-19 season amid political tension
AI psychosis sees users ‘co-creating delusions with technology’ – expert